As of June 14, 2025, Caliber Imaging & Diagnostics Inc (LCDX) reports a Net Margin of -163.99%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Caliber Imaging & Diagnostics Inc's Net Margin
Over recent years, Caliber Imaging & Diagnostics Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2013-12-31 | -163.99% |
| 2012-12-31 | -403.38% |
| 2011-12-31 | -253.12% |
| 2010-12-31 | -163.81% |
| 2009-12-31 | -183.53% |
This fluctuation highlights how Caliber Imaging & Diagnostics Inc manages its overall profitability and cost control over time.
Comparing Caliber Imaging & Diagnostics Inc's Net Margin to Peers
To better understand Caliber Imaging & Diagnostics Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Caliber Imaging & Diagnostics Inc (LCDX) | -163.99% |
| Hypertension Diagnostics Inc (HDII) | -3.31% |
| Hemagen Diagnostics Inc (HMGN) | -22.45% |
| United American Healthcare Corp (UAHC) | -23.77% |
| American Medical Technologies Inc (ADLI) | -29.08% |
| DiaSys Corp (DYXC) | -46.78% |
Compared to its competitors, Caliber Imaging & Diagnostics Inc's Net Margin is about average compared to peers, reflecting typical industry profitability.